MicroRNA-29a and microRNA-142-3p are regulators of myeloid differentiation and acute myeloid leukemia

Blood

Volumn 119, Issue 21, 2012, Pages 4992-5004

  Wang, Xiao Shuang ^a   Gong, Jia Nan ^a   Yu, Jia ^a   Wang, Fang ^a   Zhang, Xin Hua ^b   Yin, Xiao Lin ^b   Tan, Zhen Qing ^c   Luo, Zi Mian ^c   Yang, Gui Hua ^a   Shen, Chao ^a   Zhang, Jun Wu ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^b The 303rd Hospital of PLA   (China)

^c Central Hospital of Xiangtan   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CD34 ANTIGEN; CYCLIN DEPENDENT KINASE 5; CYCLIN DEPENDENT KINASE 9; CYCLIN T1; MICRORNA; MICRORNA 142 3P; MICRORNA 29A; PHORBOL 13 ACETATE 12 MYRISTATE; RETINOIC ACID; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CELL CYCLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STRAIN HL 60; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; GAIN OF FUNCTION MUTATION; GENE CONTROL; GENE TRANSFER; GRANULOCYTE; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; LENTIVIRINAE; LEUKEMIA CELL; LOSS OF FUNCTION MUTATION; MYELOID DIFFERENTIATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS REGULATION; RETINOBLASTOMA; UPREGULATION;

EID: 84861499437     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-10-385716     Document Type: Article

References (44)

1. Fröhling S, Scholl C, Gilliland DG, Levine RL. Genetics of myeloid malignancies: pathogenetic and clinical implications. J Clin Oncol. 2005;23:6285- 6295.
2. Vardiman JW, Harris NL, Brunning RD. The World Health Organization (WHO) classification of the myeloid neoplasms. Blood. 2002;100(7): 2292-2302.
3. Metcalf D. Hematopoietic cytokines. Blood. 2008; 111(2):485-491.
4. Friedman AD. Transcriptional control of granulocyte and monocyte development. Oncogene. 2007;26(47):6816-6828. (Pubitemid 47585105)
5. Auffray C, Sieweke MH, Geissmann F. Blood monocytes: development, heterogeneity, and relationship with dendritic cells. Annu Rev Immunol. 2009;27:669-692.
6. Bhana N. Granulocyte colony-stimulating factors in the management of chemotherapy-induced neutropenia: evidence based review. Curr Opin Oncol. 2007;19(4):328-335. (Pubitemid 46883521)
7. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116(2):281- 297.
8. Monticelli S, ed. MicroRNAs and the immune system: methods and protocols. Walker JM, ed. Methods in Molecular Biology, Vol. 667. Lausanne, Switzerland: Humana Press; 2010.
9. Wang F, Wang XS, Yang GH, et al. Down-regulation of miR-29a and miR-142-3p and their diagnostic implication in human acute myeloid leukemia. Mol Biol Rep. 2012;39(3):2713-2722.
10. Garzon R, Volinia S, Liu CG, et al. MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia. Blood. 2008; 111(6):3183-3189.
11. Marcucci G, Mrózek K, Radmacher MD, Garzon R, Bloomfield CD. The prognostic and functional role of microRNAs in acute myeloid leukemia. Blood. 2011;117(4):1121-1129.
12. Bellon M, Lepelletier Y, Hermine O, Nicot C. Deregulation of microRNA involved in hematopoiesis and the immune response in HTLV-I adult T-cell leukemia. Blood. 2009;113(20): 4914-4917.
13. Careccia S, Mainardi S, Pelosi A, et al. A restricted signature of miRNAs distinguishes APL blasts from normal promyelocytes. Oncogene. 2009;28(45):4034-4040.
14. Huang B, Zhao J, Lei Z, et al. miR-142-3p restricts cAMP production in CD4+CD25- T cells and CD4+CD25+ TREG cells by targeting AC9 mRNA. EMBO Rep. 2009;10(2):180-185.
15. Bissels U, Wild S, Tomiuk S, et al. Combined characterization of microRNA and mRNA profiles delineates early differentiation pathways of CD133+ and CD34+ hematopoietic stem and progenitor cells. Stem Cells. 2011;29(5):847-857.
16. Sun Y, Varambally S, Maher CA, et al. Targeting of microRNA-142-3p in dendritic cells regulates endotoxin induced mortality. Blood. 2011;117(23): 6172-6183.
17. Wu L, Cai C, Wang X, Liu M, Li X, Tang H. MicroRNA- 142-3p, a new regulator of RAC1, suppresses the migration and invasion of hepatocellular carcinoma cells. FEBS Lett. 2011;585(9): 1322-1330.
18. Lanotte M, Martin-Thouvenin V, Najman S, Balerini P, Valensi F, Berger R. NB4, a maturation inducible cell line with t(15;17) marker isolated from a human acute promyelocytic leukemia (M3). Blood. 1991;77(5):1080-1086.
19. Melnick A, Licht JD. Deconstructing a disease: RAR alpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia. Blood. 1999;93(10):3167-3215. (Pubitemid 29220886)
20. Tsuchiya S, Yamabe M, Yamaguchi Y, Kobayashi Y, Konno T, Tada K. Establishment and characterization of a human acute monocytic leukemia cell line (THP-1). Int J Cancer. 1980;26(2):171-176. (Pubitemid 10086416)
21. Pierce A, Heyworth CM, Nicholls SE, et al. An activated protein kinase C alpha gives a differentiation signal for hematopoietic progenitor cells and mimicks macrophage colony-stimulating factors- stimulated signaling events. J Cell Biol. 1998;140(6):1511-1518. (Pubitemid 28152998)
22. Breitman TR, Sclonick SE, Collins SJ. Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Proc Natl Acad Sci U S A. 1980;77(5):2936-2940. (Pubitemid 10049852)
23. Huberman E, Callaham MF. Induction of terminal differentiation in human promyelocytic leukemia cells by tumor-promoting agents. Proc Natl Acad Sci U S A. 1979;76(3):1293-1297. (Pubitemid 9143726)
24. Yang GH, Wang F, Yu J, Wang XS, Yuan JY, Zhang JW. MicroRNAs are involved in erythroid differentiation control. J Cell Biochem. 2009;107: 548-556.
25. de Falco G, Giordano A. CDK9 (PITALRE): a multifunctional cdc2-related kinase. J Cell Physiol. 1998;177(4):501-506.
26. De Luca A, Esposito V, Baldi A, et al. CDC2-related kinase PITALRE phosphorylates pRb exclusively on serine and is widely expressed in human tissues. J Cell Physiol. 1997;172(2):265- 273.
27. Simone C, Bagella L, Bellan C, Giordano A. Physical interaction between pRb and cdk9/cyclinT2 complex. Oncogene. 2002;21(26):4158- 4165.
28. Zhao JJ, Lin J, Lwin T, et al. microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma. Blood. 2010; 115(13):2630-2639.
29. Kasashima K, Nakamura Y, Kozu T. Altered expression profiles of microRNAs during TPA-induced differentiation of HL-60 cells. Biochem Biophys Res Commun. 2004;322(2):403-410. (Pubitemid 39490318)
30. Jin P, Wang E, Ren J, et al. Differentiation of two types of mobilized peripheral blood stem cells by microRNA and cDNA expression analysis. J Transl Med. 2008;6:39.
31. Chen A, Luo MY, Yuan GH, et al. Complementary analysis of microRNA and mRNA expression during phorbol 12-myristate 13-acetate (TPA)-induced differentiation of HL-60 cells. Biotechnol Lett. 2008;30:2045-2052.
32. Han Y-C, Park CY, Bhagat G, et al. microRNA- 29a induces aberrant self-renewal capacity in hematopoietic progenitors, biased myeloid development, and acute myeloid leukemia. J Exp Med. 2010;207(3):475-489.
33. Wei P, Gender ME, Fang SM, Fisher WH, Jones KA. A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA. Cell. 1998;92(4):451-462. (Pubitemid 28101109)
34. Kohoutek J, Li Q, Blazek D, Luo Z, Jiang H, Peterlin BM. Cyclin T2 is essential for mouse embryogenesis. Mol Cell Biol. 2009;29(12):3280- 3285.
35. Bergh G, Ehinger M, Olsson I, Jacobsen SE, Gullberg U. Involvement of the retinoblastoma protein in monocytic and neutrophilic lineage commitment of human bone marrow progenitor cells. Blood. 1999;94(6):1971-1978. (Pubitemid 29430413)
36. Sebastian T, Malik R, Thomas S, Sage J, Johnson PF. C/EBPbeta cooperates with RB: E2F to implement Ras(V12)-induced cellular senescence. EMBO J. 2005;24(18):3301-3312. (Pubitemid 41348704)
37. Traore K, Trush MA, George M Jr, Spannhake EW, Anderson W, Asseffa A. Signal transduction of phorbol 12-myristate 13-acetate (PMA)-induced growth inhibition of human monocytic leukemia THP-1 cells is reactive oxygen dependent. Leuk Res. 2005;29(8):863-879. (Pubitemid 40840714)
38. Rane SG, Mangan JK, Amanullah A, et al. Activation of the Jak3 pathway is associated with granulocytic differentiation of myeloid precursor cells. Blood. 2002;100(8):2753-2762.
39. Malumbres M, Sotillo R, Santamaria D, et al. Mammalian cells cycle without the D-type cyclin-dependent kinases Cdk4 and Cdk6. Cell. 2004; 118(4):493-504. (Pubitemid 39485668)
40. Fujimoto T, Anderson K, Jacobsen SEW, Nishikawa S-I, Nerlov C. Cdk6 blocks myeloid differentiation by interfering with Runx1 DNA binding and Runx1-C/EBPa interaction. EMBO J. 2007;26(9):2361-2370. (Pubitemid 46685857)
41. Morlon A, Munnich A, Munnich AS. TAB2, TRAF6 and TAK1 are involved in NF-kappaB activation induced by the TNF-receptor, Edar and its adaptor Edaradd. Hum Mol Genet. 2005;14(23):3751- 3757.
42. Takaesu G, Kishida S, Hiyama A, et al. TAB2, a novel adaptor protein, mediates activation of TAK1 MAPKKK by linking TAK1 to TRAF6 in the IL-1 signal transduction pathway. Mol Cell. 2000; 5(4):649-658.
43. Mizukami J, Takaesu G, Akatsuka H, et al. Receptor activator of NF-kappaB ligand (RANKL) activates TAK1 mitogen-activated protein kinase kinase kinase through a signaling complex containing RANK, TAB2, and TRAF6. Mol Cell Biol. 2002;22(4):992-1000. (Pubitemid 34094837)
44. Mann M, Barad O, Agami R, Geiger B, Hornstein E. miRNA-based mechanism for the commitment of multipotent progenitors to a single cellular fate. Proc Natl Acad Sci U S A. 2010; 107(36):15804-15809.